Back

Titin-truncating variants associates with atrial fibrillation, compromises assembly of the sarcomere

25 August 2018 (11:18 - 11:36)
Organised by:
Congress Presentation Part of: New approaches to the treatment of atrial fibrillation Genetics, Epigenetics, ncRNA ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Morten Olesen

University of Copenhagen, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
New approaches to the treatment of atrial fibrillation - State of the art
Professor D. Dobrev (Essen, DE)
Presentation thumbnail
Local optogenetic therapy for acute shock-free termination of atrial fibrillation in vivo
Doctor E. Nyns (Rotterdam, NL)
Abstract
Presentation thumbnail
Inhibition of TASK-1 by gene therapy and pharmacological compounds suppresses atrial fibrillation in a large animal model
Doctor C. Schmidt (Goettingen, DE)
Abstract
Presentation thumbnail
Translational challenges in atrial fibrillation
Professor H. Spronk (Maastrich, NL)
Slides Video

Access the full session

Session thumbnail
New approaches to the treatment of atrial fibrillation

The Event

Event poster

ESC Congress 2018

25 August 2018 11:18 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources